Showing 4181-4190 of 5062 results for "".
Interoperability Redux
https://practicaldermatology.com/topics/practice-management/interoperability-redux/20455/Is the new push for interoperability déjà vu all over again?Currents: Reboot Your Practice
https://practicaldermatology.com/topics/practice-management/currents-reboot-your-practice/20638/How To (and How Not To) Build Your Email List
https://practicaldermatology.com/topics/practice-management/how-to-and-how-not-to-build-your-email-list/20636/In an era when we are all inundated with excess email, how can you convince people to subscribe to your newsletter and announcements?Interoperability Update
https://practicaldermatology.com/topics/practice-management/interoperability-update/20674/Are PHRs the key to interoperability?The Logistics of Biologics
https://practicaldermatology.com/topics/psoriasis/the-logistics-of-biologics/22932/The road from prescription to administering biologic agents may not always be smooth, but these clinical and practical tips will help to expedite the process.Connecting the Dots
https://practicaldermatology.com/topics/practice-management/connecting-the-dots/20890/A guide to understanding millennials.Google Authorship Can Boost a Dermatologist's Online Profile
https://practicaldermatology.com/topics/practice-management/google-authorship-can-boost-a-dermatologists-online-profile/21437/The Changing SEO Paradigm for Your Dermatology Website
https://practicaldermatology.com/topics/practice-management/the-changing-seo-paradigm-for-your-dermatology-website/22927/The SEO approach to marketing is rapidly undergoing a paradigm shift. Are you geared up for the change?Clinical Updates on Psoriasis Management
https://practicaldermatology.com/topics/psoriasis/clinical-updates-on-psoriasis-management/21496/Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/videos/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.